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ABSTRACT
Objective Interleukin-6 (IL6; proinflammatory marker),
von Willebrand Factor (vWF; endothelial dysfunction
marker) and P-selectin (platelet activation marker), may
play important roles in defining the pathogenesis of
vulnerable plaques in acute coronary syndrome (ACS).
This study aims to investigate the expression and
relationship of these markers in early phases of ACS in a
young and multiethnic Malaysian population.
Design Peripheral whole blood mRNA, and serum levels
of IL6, vWF and P-selectin were measured in 22 patients
with ACS, and in 28 controls with angiographically
significant coronary artery disease without previous ACS
events. Venous blood from ACS patients was obtained
within 1 h of hospital admission.
Results No significant differences of IL6, vWF and
P-selectin mRNA levels between ACS and controls were
seen. ACS patients had significantly higher serum levels
of IL6 and vWF (p<0.001), compared with controls.
P-selectin correlated with IL6 (r=0.697, p=0.003) and
vWF (r=0.497, p=0.05) at mRNA levels, indicating a
possible association between these three indices of ACS
pathogenesis.
Conclusions Increased serum levels of IL6 and vWF
suggest that inflammation and endothelial dysfunction
may play a prominent role in the pathogenesis of the
disease during the early phase of ACS.
INTRODUCTION
Coronary artery disease (CAD), including its mani-
festation as acute coronary syndrome (ACS) is a well
established cause of morbidity and mortality among
adults in both developed and developing countries.
In recent years, there has been an alarming rise in
the incidence of ACS in the Malaysian population,
especially in younger age groups.1 It has been
reported that Malaysian ACS patients had a median
age of 59 years, which was comparatively younger
than the Caucasian population, whose median age
was 66 years, as shown by the international multi-
centre GRACE Registry.1 2
Atherosclerosis is the culprit behind the ACS
and stable CAD. The pathophysiology of athero-
sclerosis includes plaque formation and destabilisa-
tion (‘atherogenesis’), tendency to thrombus
formation (‘thrombogenesis’), and the loss of
endothelial cell integrity (‘endothelial dysfunc-
tion’) within the coronary arteries, as described by
Virchow’s vascular triad.3 These processes are
intimately linked, and hence, provide a clue of
diagnosis of eventual ACS as early as in pathogen-
esis of disease based on composition and vulner-
ability of plaque.4
Currently available cardiac markers for ACS diag-
nosis, such as troponin-T and creatine kinase–myo-
cardial band (CK-MB) isoenzyme, only detect
consequences of myocardial damage after ACS has
occurred, thus the information to identify patients
at risk of ACS in early phase is not available.5 Much
interest has focused on identifying upstream
markers which can detect an individual at risk of
atherosclerotic plaque rupture leading to ACS. These
include markers of inflammation, interleukin 6
(IL6); endothelial dysfunction, von Willenbrand
Factor (vWF), and platelet activation, P-selectin.
Although each of these markers has been shown to
predict future cardiovascular events in stable CAD
patients, as well as recurrent events and death in
patients presenting with ACS,6–8 their association
has yet to be studied in a young, multiethnic group
of the Malaysian population.
It now supports the concept that all types of
blood constituents appear to play a role in plaque
formation,9 and the peripheral blood gene expression
may reflect pathophysiology in the vascular wall or
the extent of CAD.10 With increasing awareness of
the practical limitations of collecting primary car-
diovascular disease tissue, temporal evaluation of
blood RNA profiles that are mechanistically asso-
ciated with disease processes could provide an add-
itional useful tool for screening for disease in an
at-risk population. Moreover, studying both tran-
scriptional and translational profiles of markers
could lead us to understand the in vivo molecular
pathway of atherogenesis, endothelial dysfunction
and platelet activation in patients with ACS.
By specifically choosing different aspects of the
pathophysiology of atherosclerotic plaque rupture,
the present study sought to investigate whether
IL6, vWF and P-selectin can be used as markers to
differentiate patients who had developed ACS,
compared with patients with stable CAD during
an early phase of hospitalisation.
MATERIALS AND METHODS
Study participants
Twenty-two ACS patients, who had transient
ST-segment or T-wave changes on a standard
12-lead electrocardiogram, or raised troponin-T
levels occurring with their typical symptom
onset, were recruited into this study between
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